USE OF PROCALCITONIN (PCT) FOR RISK TRACTIFICATION AND PROGNOSIS IN PATIENTS WITH A PRIMARY NONINFECTIOUS ILLNESS

摘要

Subject of the present invention are assays and in vitro methods for the in vitro diagnosis, prognosis and risk stratification of a patient having a primary, non-infectious disease, whereby the level of Procalcitonin (PCT) in a sample of a body fluid of the patient is indicative for the risk of the patient to contract a further disease or medical condition.